Acquisition of organoplate graft to be used for sars_COV-2 project
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00365
- Awardee
-
Mimetas Operations US, CO. UEI M9RJXA9M7L68
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $150,480
Award facts
- Opportunity
-
- Acquisition of OrganoPlate Graft to be used for SARS_CoV-2 Project Pre-Solicitation · 75N95022Q00344 · Posted May 18, 2022
- Contract value 100% obligated
- $150,480.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Gaithersburg, MD 20878, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$33,264 | |
| Other Administrative Action | $0 | |
| Original award | $183,744 |
About this award
This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services (HHS), to Mimetas Operations US, Co., a foreign-owned, self-certified small disadvantaged business. The $150,480.00 contract is for the acquisition of Organoplate Grafts, which are microfluidic 3D cell culture plates used in scientific research projects related to SARS-CoV-2 and COVID-19. This contract was awarded under a pre-solicitation opportunity posted on May 18, 2022, and does not have a set-aside designation. The contractor has a history of providing these products to NCATS/NIH for various research efforts.
Quick answers
Who was awarded contract 75N95022P00365?
75N95022P00365 was awarded to Mimetas Operations US, CO. by National Institute on Drug Abuse (National Institutes of Health) on July 22, 2022.
How much is contract 75N95022P00365 worth?
The government has obligated $150,480 on 75N95022P00365.
Which agency awarded contract 75N95022P00365?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00365, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00365 competed?
The extent of competition for 75N95022P00365 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award